Rising Prevalence Of Respiratory Diseases Fuels Growth In The Dry Powder Inhaler Market: A Key Driver Powering Dry Powder Inhaler Market Growth In 2025

The Dry Powder Inhaler Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Dry Powder Inhaler Market Size and Its Estimated Growth Rate?
In recent times, the dry powder inhaler market has seen substantial growth. The market which is projected to increase from $21.25 billion in 2024 to $22.35 billion in 2025 will do so at a compound annual growth rate (CAGR) of 5.2%. The previously observed growth in this market can be linked to factors including renewed enthusiasm for sustainable building materials, a surge in the practice of green building, increased interest in the preservation of cultural heritage and antiquities restoration, localized sourcing, community engagement, along with regulatory backing and construction regulations.

In the coming years, the dry powder inhaler market is anticipated to maintain a stable growth trajectory, culminating in a market valuation of $27.13 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.0%. This growth during the forecast period can be ascribed to various factors such as sustained focus on sustainability, worldwide urbanization patterns, enhancements in production processes, governmental incentives and strategies, as well as international economic elements. The forecast period will also witness major trends, including a surge in research and development efforts, a revived focus on traditional construction techniques, breakthroughs in material technology, architectural and design movements, and regulatory backing for sustainable construction.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13430

How Are Emerging Segments Shaping the Dry Powder Inhaler Market Landscape?
The dry powder inhaler market covered in this report is segmented -

1) By Product: Single-Dose Inhalers, Multi-Dose Inhalers
2) By Function: Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices
3) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Other Applications
4) By End User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Single-Dose Inhalers: Capsule-Based Inhalers, Diskus-Based Inhalers
2) By Multi-Dose Inhalers: Blister-Based Inhalers, Rotahaler-Based Inhalers

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13430&type=smp

Which Growth Factors Are Influencing Dry Powder Inhaler Market Expansion?
The dry powder inhaler market is anticipated to grow due to the increasing occurrences of respiratory diseases. Respiratory diseases, which include various lung diseases and respiratory disorders, primarily affect the respiratory system. Dry powder inhalers play a crucial role in the treatment of these diseases, such as asthma, COPD, and cystic fibrosis, by delivering medication directly to the lungs. This makes them an effective alternative to traditional drug delivery methods. For example, a research study published by JAMA Network Open in December 2023 predicted that the number of COPD cases worldwide could reach around 600 million by 2050, a 23% rise in prevalence. The study also indicated a potential surge of 47.1% in female cases while male cases are expected to increase by 9.4%. It is also anticipated that the majority of these cases will be in low- and middle-income areas, where the prevalence could be double that of high-income areas by 2050. Consequently, the increase in respiratory diseases is likely to augment the growth of the dry powder inhaler market. Dry Powder Inhaler Market Driver: The Influence of Increasing Air Pollution Levels on the Growth of the Dry Powder Inhaler Market

Who Are the Dominant Players Across Different Dry Powder Inhaler Market Segments?
Major companies operating in the dry powder inhaler market report are Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Boehringer Ingelheim GmbH, Viatris (Mylan N.V), Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici S.p.A., Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, OPKO Health, Zhejiang Hisun Pharmaceutical Co Ltd., Beximco Pharmaceuticals Ltd., Sava Healthcare Ltd., Hovione, Elpen S.A., MannKind Corporation, Meda Pharmaceuticals, Presspart Manufacturing Ltd., SMB Laboratories SA, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.

What Are the Latest Developing Trends in the Dry Powder Inhaler Market?
Leading firms in the dry powder inhaler market are advancing their product roster by introducing innovative goods that incorporate muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). A muscarinic antagonist is a medicinal compound that hinders the muscarinic acetylcholine receptor, for controlling and treating various disorders, including COPD and organophosphate poisoning. For example, Berry Global, a prominent U.S. firm recognized for its development and manufacture of an extensive variety of adaptable packaging solutions, debuted its new dry powder inhaler in March 2024 at Pharmapack. The inhaler's design optimizes drug delivery for respiratory conditions like COPD and asthma, thereby providing a customizable solution for pharmaceutical companies.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/dry-powder-inhaler-global-market-report

Which Geographic Regions Are Expected to Dominate the Dry Powder Inhaler Market in the Coming Years?
North America was the largest region in the dry powder inhaler market in 2024. The regions covered in the dry powder inhaler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Dry Powder Inhaler Market?
2. What is the CAGR expected in the Dry Powder Inhaler Market?
3. What Are the Key Innovations Transforming the Dry Powder Inhaler Industry?
4. Which Region Is Leading the Dry Powder Inhaler Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.